Education Agreement To Advance Psma-Informed Prostate Care
09/10/2026 12:59
BRIEF-Profound Medical And Telix Pharmaceuticals Enter Co-Education Agreement To Advance Psma-Informed Prostate Care Oct 9 (Reuters) - Profound Medical Corp PRN.TO:
PROFOUND MEDICAL AND TELIX PHARMACEUTICALS ENTER CO-EDUCATION AGREEMENT TO ADVANCE PSMA-INFORMED PROSTATE CARE
Source text: ID:nGNX3MDjRf
Further company coverage: PRN.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Telix Pharmaceuticals
See all newsJefferies cuts price target on Telix Pharmaceuticals following quarterly update
Australia's Telix Pharmaceuticals slides on sequential fall in quarterly revenue
Brief: Telix Pharmaceuticals Limited Reports Qtrly Group Revenue Of $245 Million
Education Agreement To Advance Psma-Informed Prostate Care
Australia's Telix rises after dosing first US patients with brain cancer imaging drug